Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Fintel reports that on January 8, 2025, Stifel initiated coverage of Altimmune (NasdaqGM:ALT) with a Buy recommendation.
Fintel reports that on January 8, 2025, Stifel initiated coverage of Structure Therapeutics Inc. - Depositary Receipt () ...
Stifel analysts raised their price target to $31.00 from $26.00 and reiterated a Buy rating on Rocket Lab ( RKLB, Financial) ...
DoubleVerify shares jumped 6% by noon trading on Wednesday after it was revealed by Stifel that the software platform will ...
Stifel notes that the firm is about 75% done with its Q4 advertising checks and believes Q4 was “very healthy despite a shorter holiday ...
The analyst's findings offer a glimpse into DoubleVerify's business strategy, potentially signaling a stronger financial outlook for the company if the price increase is implemented. The news has ...